Goal-orientated Therapy of Perioperative Disturbance in Hemostasis in Cardiac Surgery

Aim of this study is to investigate whether patients preoperatively treated with acetylsalicylic acid and/or clopidogrel have fewer perioperative bleeding and lower amounts of blood substitution when managed by ROTEM (whole blood coagulation analyzer) and MULTIPLATE (thrombocyte function analyzer).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Coronary Artery Bypass Graft Triple Vessel Blood Coagulation Disorders Hematologic Diseases Hemic and Lymphatic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Basel

Basel, CH, 4031, Switzerland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

written consent

Exclusion criteria

no written consent

Treatment and study plan

Primary outcomes

Perioperative blood loss

Time frame: 24 hours

Secondary outcomes

perioperative substitution with erythrocyte concentrates, thrombocyte concentrates or fresh frozen plasma

Time frame: 24 hours and 7 days

Sponsors and collaborators

Lead sponsor

University Hospital, Basel, Switzerland

Other

Registry information

Official study title

Goal-orientated Therapy of Perioperative Disturbance in Hemostasis With MULTIPLATE and ROTEM in Cardiac Surgery Patients Under Platelets Inhibitors

Important dates

Study start: 2009
Primary completion: 2011
Study completion: 2011
First posted: Aug 14, 2007
Registry last updated: Jan 11, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed